NASDAQ: CLPT
Clearpoint Neuro Inc Stock

$18.32-0.06 (-0.33%)
Updated Feb 14, 2025
CLPT Price
$18.32
Fair Value Price
-$17.73
Market Cap
$505.35M
52 Week Low
$5.11
52 Week High
$19.22
P/E
-26.94x
P/B
17.43x
P/S
10.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$30.43M
Earnings
-$18.15M
Gross Margin
60.4%
Operating Margin
-60.26%
Profit Margin
-59.6%
Debt to Equity
0.39
Operating Cash Flow
-$9M
Beta
1.23
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CLPT Overview

ClearPoint Neuro, Inc. is a medical device company developing platforms for performing minimally invasive surgical procedures in the brain under direct and intra-procedural magnetic resonance imaging (MRI ) guidance. It offers the ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters, into the brain. The ClearPoint Neuro Navigation System is an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, and others. ClearPoint Neuro was incorporated in 1998 and is headquartered in Solana Beach, CA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CLPT's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
B
Momentum
C
Sentiment
C
Safety
C
Financials
D
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
CLPT
Ranked
#46 of 129

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$31.89A
$10.41A
$47.68A
View Top Medical Device Stocks

Be the first to know about important CLPT news, forecast changes, insider trades & much more!

CLPT News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLPT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLPT ($18.32) is overvalued by 203.33% relative to our estimate of its Fair Value price of -$17.73 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CLPT ($18.32) is not significantly undervalued (203.33%) relative to our estimate of its Fair Value price of -$17.73 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CLPT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CLPT due diligence checks available for Premium users.

Valuation

CLPT fair value

Fair Value of CLPT stock based on Discounted Cash Flow (DCF)

Price
$18.32
Fair Value
-$17.73
Undervalued by
203.33%
CLPT ($18.32) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CLPT ($18.32) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CLPT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CLPT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-26.94x
Industry
42.37x
Market
37.92x

CLPT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
17.43x
Industry
4.36x
CLPT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLPT's financial health

Profit margin

Revenue
$8.1M
Net Income
-$5.0M
Profit Margin
-61.2%
CLPT's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
CLPT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$40.2M
Liabilities
$11.2M
Debt to equity
0.39
CLPT's short-term assets ($34.33M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLPT's short-term assets ($34.33M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLPT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLPT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
-$12.0k
Financing
-$10.1M
CLPT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CLPT vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CLPTC$505.35M-0.33%-26.94x17.43x
PACBC$506.65M+25.00%-1.27x1.12x
DCTHB$520.53M0.00%-13.57x60.73x
SRDXC$487.49M-0.18%-33.43x4.36x
VREXB$546.72M-2.50%-11.25x1.01x

Clearpoint Neuro Stock FAQ

What is Clearpoint Neuro's quote symbol?

(NASDAQ: CLPT) Clearpoint Neuro trades on the NASDAQ under the ticker symbol CLPT. Clearpoint Neuro stock quotes can also be displayed as NASDAQ: CLPT.

If you're new to stock investing, here's how to buy Clearpoint Neuro stock.

What is the 52 week high and low for Clearpoint Neuro (NASDAQ: CLPT)?

(NASDAQ: CLPT) Clearpoint Neuro's 52-week high was $19.22, and its 52-week low was $5.11. It is currently -4.68% from its 52-week high and 258.86% from its 52-week low.

How much is Clearpoint Neuro stock worth today?

(NASDAQ: CLPT) Clearpoint Neuro currently has 27,584,699 outstanding shares. With Clearpoint Neuro stock trading at $18.32 per share, the total value of Clearpoint Neuro stock (market capitalization) is $505.35M.

Clearpoint Neuro stock was originally listed at a price of $30.00 in May 22, 2012. If you had invested in Clearpoint Neuro stock at $30.00, your return over the last 12 years would have been -38.93%, for an annualized return of -4.03% (not including any dividends or dividend reinvestments).

How much is Clearpoint Neuro's stock price per share?

(NASDAQ: CLPT) Clearpoint Neuro stock price per share is $18.32 today (as of Feb 14, 2025).

What is Clearpoint Neuro's Market Cap?

(NASDAQ: CLPT) Clearpoint Neuro's market cap is $505.35M, as of Feb 16, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Clearpoint Neuro's market cap is calculated by multiplying CLPT's current stock price of $18.32 by CLPT's total outstanding shares of 27,584,699.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.